Automated solvent system screening for the preparative countercurrent chromatography of pharmaceutical discovery compounds

Liquid-Liquid Chromatography: Current Design Approaches and Future Pathways

Since its first appearance in the 1960s, solid support-free liquid-liquid chromatography has played an ever-growing role in the field of natural products research. The use of the two phases of a liquid biphasic system, the mobile and stationary phases, renders the technique highly versatile and adaptable to a wide spectrum of target molecules, from hydrophobic to highly polar small molecules to proteins. Generally considered a niche technique used only for small-scale preparative separations, liquid-liquid chromatography currently lags far behind conventional liquid-solid chromatography and liquid-liquid extraction in process modeling and industrial acceptance. This review aims to expose a broader audience to this high-potential separation technique by presenting the wide variety of available operating modes and solvent systems as well as structured, model-based design approaches. Topics currently offering opportunities for further investigation are also addressed.

Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review

Alzheimer's disease (AD) is the most common progressive neurodegenerative disorder characterized by neuronal loss and cognitive impairment that harshly affect the elderly individuals. Currently, the available anti-AD pharmacological approaches are purely symptomatic to alleviate AD symptoms, and the curative effects of novel anti-AD drugs focused on Aβ target are disappointing. Hence, there is a tremendous need to adjust AD therapeutic targets and discover novel anti-AD agents. In AD, mitochondrial dysfunction gradually triggers neuronal death from different aspects and worsens the occurrence and progress of AD. Consequently, it has been proposed that the intervention of impaired mitochondria represents an attractive breakthrough point for AD treatments. Due to chemical diversity, poly-pharmacological activities, few adverse effects and multiple targeting, natural products (NPs) have been identified as a valuable treasure for drug discovery and development. Multiple lines of studies have scientifically proven that NPs display ameliorative benefits in AD treatment in relation to mitochondrial dysfunction. This review surveys the complicated implications for mitochondrial dysregulation and AD, and then summarizes the potentials of NPs and their underlying molecular mechanisms against AD via reducing or improving mitochondrial dysfunction. It is expected that this work may open the window to speed up the development of innovative anti-AD drugs originated from NPs and improve upcoming AD therapeutics.

Stepwise elution by high-speed counter-current chromatography combined with a modified macroporous resin to isolate and purify antioxidant phenolics from discarded jackfruit (Artocarpusheterophyllus Lam.) peels

Combined with modified macroporous resin (MR), high-speed counter-current chromatography (HSCCC) was developed to separate and purify the antioxidant phenolics from waste jackfruit peels. First, the 4,4'-bis(chloromethyl)-1,1'-biphenyl was used to modify the commercially available adsorbent resin XAD-4 in order to enrich the antioxidant phenolics. Second, the resultant phenolics-rich fractions were further purified by HSCCC. In the separation process, the petroleum ether-ethyl acetate-methanol-0.1% acetic acid (5 : 5 : 3 : 7, v/v) upper phase was employed as an immobile phase. Afterwards, stepwise elution using petroleum the ether-ethyl acetate-methanol-0.1% acetic acid (5 : 5 : 3 : 7, v/v) lower phase was carried out during the initial 3.5 h, whereas the petroleum ether-ethyl acetate-methanol-0.1% acetic acid (5 : 5 : 6 : 4, v/v) lower phase was adopted for stepwise elution during the later 2.0 h. Four phenolics were obtained from 179 mg of the phenolics-rich fraction in a single run, including 41 mg chlorogenic, 27 mg gallic acid, 33 mg quercetin, and 29 mg catechin. 13C NMR, 1H NMR, and ESI-MS were employed to identify their structures.

Operating mode and parameter selection in liquid-liquid chromatography

The presence of a liquid stationary phase in liquid-liquid chromatography (LLC) allows for high versatility of operation as well as adaptability to different sample types and separation tasks. LLC, also known as countercurrent chromatography (CCC) or centrifugal partition chromatography (CPC), offers the user a variety of operating modes, many of which have no direct equivalent in conventional preparative liquid-solid chromatography. These operating modes have the potential to greatly improve LLC separation performance compared to the standard "classical" isocratic batch injection mode, and they often require minimal to no addition of equipment to the standard set-up. However, reports of the use of alternative LLC operating modes make up only a fraction of the literature. This is likely due, at least in part, to the lack of clear guidelines and methods for operating mode and parameter selection, leaving alternative process options to be avoided and underutilized. This review seeks to remedy this by providing a thorough overview of the available LLC operating modes, identifying the key characteristics, advantages and disadvantages, and areas of application of each. Additionally, the equations and short-cut models aiding in operating mode and parameter selection are presented and critiqued, and their notation is unified for clarity. By rendering LLC and its alternative operating modes more accessible to current and prospective users, it is hoped to help expand the application of this technology and support the achievement of its full potential.